Inventor · disambiguated record
Hermann Tenor
Also filed as: TENOR HERMANN
11 granted patents·9 pending applications·3 citations·filing 2006–2025
81Inventor score
Top patents by PatentIndex Score
20 records- 0183US12351585B22-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2023·Granted Jul 8, 2025·0 cites·20 claims
- 0276US11897890B22-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2021·Granted Feb 13, 2024·0 cites·8 claims
- 0374US2024360136A1Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2023·Application pending·0 cites
- 0471US11905293B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2021·Granted Feb 20, 2024·0 cites·21 claims
- 0571US2025320216A1Phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2025·Application pending·0 cites
- 0668US8609848B2Pyrazolone-derivatives and their use as PDE-4 inhibitorsSCHLEMMINGER IMRE·Filed 2009·Granted Dec 17, 2013·2 cites·15 claims
- 0766US11242347B22-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2020·Granted Feb 8, 2022·0 cites·20 claims
- 0861US9018175B23,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivativesFLOCKERZI DIETER·Filed 2010·Granted Apr 28, 2015·1 cites·19 claims
- 0958US2011136803A1TriazolophthalazinesNYCOMED GMBH·Filed 2009·Application pending·0 cites
- 1057US9340522B2Pyrazolone-derivatives and their use as PDE-4 inhibitorsTAKEDA GMBH·Filed 2013·Granted May 17, 2016·0 cites·8 claims
- 1156US10570137B22-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2016·Granted Feb 25, 2020·0 cites·20 claims
- 1254US11155558B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2018·Granted Oct 26, 2021·0 cites·20 claims
- 1353US2025000869A1Topical compositions of 2-phenyl-3, 4-dihydropyrrolo [2, l-f] [1, 2, 4] triazinone derivatives and uses thereofTOPADUR PHARMA AG·Filed 2022·Application pending·0 cites
- 1441US2010286140A1TriazolophthalazinesNYCOMED GMBH·Filed 2010·Application pending·0 cites
- 1540US12502393B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2019·Granted Dec 23, 2025·0 cites·18 claims
- 1638US2016108049A1Novel Phthalazinone-Pyrrolopyrimidinecarboxamide DerivativesTAKEDA GMBH·Filed 2015·Application pending·0 cites
- 1736US2014112945A1Novel phthalazinone-pyrrolopyrimidinecarboxamide derivativesSTENGEL THOMAS·Filed 2012·Application pending·0 cites
- 1834US2014113877A1Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c] isoquinoline compoundsFLOCKERZI DIETER·Filed 2012·Application pending·0 cites
- 1932US8648100B2Roflumilast for the treatment of pulmonary hypertensionBEUME ROLF·Filed 2006·Granted Feb 11, 2014·0 cites·5 claims
- 2029US2016339010A1Treatment of Partly Controlled or Uncontrolled Severe AsthmaTAKEDA GMBH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hermann Tenor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →